Support is requested to continue a program aimed at understanding fundamental aspects of hemostasis and thrombosis by defining key mechanisms that regulate thrombus formation in response to wounding or vascular disease. The proposed studies - which utilize reverse genetic, biochemical and structural approaches combined with ex vivo and in vivo videomicroscopy analyses of blood interaction with reactive surfaces under specified hemodynamic conditions - are designed to lead to new approaches for the diagnosis, treatment and prevention of thrombosis. The program will consist of four projects and two core units. Dr. Ruggeri will study the interplay of different constituents responsible for the variable thrombogenicity of extracellular matrices and cell surfaces exposed to flowing blood, and define the mechanisms that regulate the response of platelets to such diverse stimuli. Dr. Ginsberg will define the cellular and extracellular molecular associations and the signaling mechanisms that are responsible for the assembly of extracellular matrices. Dr. Ruf will focus on the modulation of tissue factor procoagulant and signaling activities and the role of these mechanisms in regulating the response to injury and the thrombogenicity of cellular and extracellular vascular surfaces. Dr. Griffin will explore the role of the protein C-dependent pathway in thrombotic and inflammatory processes, and define the bases for the use of recombinant activated protein C species as potential therapeutic agents. Core A will support ex vivo and in vivo models of hemostasis and thrombosis for use by all the projects, and core B will provide administrative support to facilitate the development of the specific aims of the program in a collegial environment. There will be strong interactions and synergy of efforts among all the projects, centered on multifaceted approaches to the study of what constitutes a thrombogenic surface and the mechanisms that initiate and regulate the response of platelets and the coagulation system to different vascular lesions.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL031950-24
Application #
7487305
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Program Officer
Link, Rebecca P
Project Start
1996-12-01
Project End
2010-08-31
Budget Start
2008-09-01
Budget End
2009-08-31
Support Year
24
Fiscal Year
2008
Total Cost
$2,141,443
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Klann, Jane E; Kim, Stephanie H; Remedios, Kelly A et al. (2018) Integrin Activation Controls Regulatory T Cell-Mediated Peripheral Tolerance. J Immunol 200:4012-4023
Griffin, John H; Zlokovic, Berislav V; Mosnier, Laurent O (2018) Activated protein C, protease activated receptor 1, and neuroprotection. Blood 132:159-169
Sinha, Ranjeet K; Wang, Yaoming; Zhao, Zhen et al. (2018) PAR1 biased signaling is required for activated protein C in vivo benefits in sepsis and stroke. Blood 131:1163-1171
Xu, Xiaohong Ruby; Wang, Yiming; Adili, Reheman et al. (2018) Apolipoprotein A-IV binds ?IIb?3 integrin and inhibits thrombosis. Nat Commun 9:3608
Gupta, Naveen; Liu, Roland; Shin, Stephanie et al. (2018) SCH79797 improves outcomes in experimental bacterial pneumonia by boosting neutrophil killing and direct antibiotic activity. J Antimicrob Chemother 73:1586-1594
Gupta, Naveen; Sinha, Ranjeet; Krasnodembskaya, Anna et al. (2018) The TLR4-PAR1 Axis Regulates Bone Marrow Mesenchymal Stromal Cell Survival and Therapeutic Capacity in Experimental Bacterial Pneumonia. Stem Cells 36:796-806
Amar, Arun Paul; Sagare, Abhay P; Zhao, Zhen et al. (2018) Can adjunctive therapies augment the efficacy of endovascular thrombolysis? A potential role for activated protein C. Neuropharmacology 134:293-301
Klann, Jane E; Remedios, Kelly A; Kim, Stephanie H et al. (2017) Talin Plays a Critical Role in the Maintenance of the Regulatory T Cell Pool. J Immunol 198:4639-4651
Deguchi, Hiroshi; Navarro, Silvia; Payne, Amanda B et al. (2017) Low level of the plasma sphingolipid, glucosylceramide, is associated with thrombotic diseases. Res Pract Thromb Haemost 1:33-40
Kamikubo, Yuichi; Mendolicchio, G Loredana; Zampolli, Antonella et al. (2017) Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex. Blood 130:1661-1670

Showing the most recent 10 out of 428 publications